When it comes to fighting the coronavirus, Israel is discovering the limits of vaccines. The country famous for its high-tech prowess and spirit of innovation is home to the world’s speediest vaccination drive, fueled from the top by national pride and a deep longing to start “getting back to life,” as Prime Minister Benjamin Netanyahu put it. But experts say reopening the country will still take months, complicated by coronavirus mutations that have spread from Britain and South Africa, and wobbles in the pace of vaccinations of people under 60. While the government is expected to begin easing a third nationwide lockdown in the coming days, there are likely to be further, partial closings as the threat ebbs and flows. “This is going to be a balancing act,” said Eyal Leshem, director of the Center for Travel Medicine and Tropical Diseases at Sheba Medical Center. In an impressive feat, more than a third of Israel’s 9.3 million people have received at least one shot in mere weeks, and over 1.9 million have gotten both doses, perhaps putting the country on track to inoculate nearly its entire adult population by the end of March. In Israel, for the first time, researchers are starting to see the effects of the vaccinations, giving other nations a very early glimpse of what might lie ahead for them. Netanyahu on Thursday said that among people over 60, the first group vaccinated, serious cases of hospitalizations have dropped 26% and confirmed infections have fallen 45% over the past 16 days. “This is a direct result of the vaccinations,” he said. “The vaccines work.” But other key indicators, including deaths and new infections, remain high, in part because of the fast-spreading mutations, the month-long lag time before the vaccine shows its full benefits and an apparent reluctance among other parts of society to get vaccinated. Israel has been reporting some 7,000 new infections a day, one of the highest rates in the developed world. Nearly 5,000 people have died, more than a quarter of them in January alone. Israel has certain advantages that suggest its success at vaccinations may not be easily duplicated elsewhere. It is small, with 9.3 million people. It has a centralized and digitized system of health care, delivered through just four HMOs. And its leader, Netanyahu, has made the vaccination drive a centerpiece of his bid for reelection in March, personally negotiating deals with the CEOs of Pfizer and Moderna. Still, experts around the world are watching eagerly. “Israel’s aggressive inoculation program demonstrates that it is indeed possible for a country to get vaccines into people’s arms quickly and efficiently,” said Jonathan Crane, a bioethicist at Emory University in Atlanta. In an email, he praised the centralized effort, compared with the “piecemeal” way vaccines in countries like the U.S. are being delivered by various jurisdictions. Dr. Michael Thieren, the World Health Organization’s representative in Israel and Europe’s special adviser on COVID-19, called the Israeli campaign “outstanding” and said it could only happen in a country with strong universal health coverage. He said the high rate of vaccinations means vulnerable populations will be protected, and as the campaign expands, the number and severity of cases should decrease. But the exact timeframe is difficult to predict. Given many unknowns, such as the duration of protection […]
The post As Variants Run Amok, Israel Learns Limits Of Vaccines appeared first on The Yeshiva World.